| Year |
Citation |
Score |
| 2023 |
Collij LE, Farrar G, Zwan M, van de Giessen E, Ossenkoppele R, Barkhof F, Rozemuller AJM, Pijnenburg YAL, van der Flier WM, Bouwman F. Clinical outcomes up to 9 years after [F]flutemetamol amyloid-PET in a symptomatic memory clinic population. Alzheimer's Research & Therapy. 15: 207. PMID 38012799 DOI: 10.1186/s13195-023-01351-1 |
0.311 |
|
| 2022 |
Ingala S, van Maurik IS, Altomare D, Wurm R, Dicks E, van Schijndel RA, Zwan M, Bouwman F, Schoonenboom N, Boelaarts L, Roks G, van Marum R, van Harten B, van Uden I, Claus J, et al. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease. European Radiology. PMID 35639148 DOI: 10.1007/s00330-021-08503-7 |
0.306 |
|
| 2022 |
van der Doelen DM, Handels RLH, Zwan MD, van Kuijk SMJ, Pelkmans W, Bouwman FH, Scheltens P, Dirksen CD, Verhey FRJ. The Impact of Amyloid PET Disclosure on Quality of Life in Patients With Young Onset Dementia. Alzheimer Disease and Associated Disorders. 36: 1-6. PMID 35200198 DOI: 10.1097/WAD.0000000000000470 |
0.322 |
|
| 2021 |
Collij LE, Salvadó G, Shekari M, Alves IL, Reimand J, Wink AM, Zwan M, Niñerola-Baizán A, Perissinotti A, Scheltens P, Ikonomovic MD, Smith APL, Farrar G, Molinuevo JL, Barkhof F, et al. Visual assessment of [F]flutemetamol PET images can detect early amyloid pathology and grade its extent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33615397 DOI: 10.1007/s00259-020-05174-2 |
0.305 |
|
| 2019 |
Reimand J, de Wilde A, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, Barkhof F, van der Flier WM, Scheltens P, van Berckel BNM, Ossenkoppele R, Bouwman F. PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases. Alzheimer's Research & Therapy. 11: 100. PMID 31810489 DOI: 10.1186/S13195-019-0561-5 |
0.311 |
|
| 2019 |
de Wilde A, Ossenkoppele R, Pelkmans W, Bouwman F, Groot C, van Maurik I, Zwan M, Yaqub M, Barkhof F, Lammertsma AA, Biessels GJ, Scheltens P, van Berckel BN, van der Flier WM. Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31594684 DOI: 10.1016/J.Jalz.2019.07.003 |
0.321 |
|
| 2019 |
de Wilde A, Reimand J, Teunissen CE, Zwan M, Windhorst AD, Boellaard R, van der Flier WM, Scheltens P, van Berckel BNM, Bouwman F, Ossenkoppele R. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences. Alzheimer's Research & Therapy. 11: 78. PMID 31511058 DOI: 10.1186/S13195-019-0532-X |
0.301 |
|
| 2019 |
Rodríguez-Gómez O, Rodrigo A, Iradier F, Santos-Santos MA, Hundemer H, Ciudin A, Sannemann L, Zwan M, Glaysher B, Wimo A, Bonn J, Johansson G, Rodriguez I, Alegret M, Gove D, et al. The MOPEAD project: Advancing patient engagement for the detection of "hidden" undiagnosed cases of Alzheimer's disease in the community. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31076376 DOI: 10.1016/J.Jalz.2019.02.003 |
0.326 |
|
| 2019 |
Handels R, Zwan MD, Pelkmans W, Bouwman FH, Biessels GJ, Roks G, Schoonenboom NSM, Verwey NA, Berckel BNMV, Flier WMvd, Verhey FRJ, Scheltens P. Added Diagnostic Value Of 18F-Flutemetamol Pet Scanning In Young Patients With Dementia Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2772 |
0.329 |
|
| 2018 |
Willemse EAJ, van Maurik IS, Tijms BM, Bouwman FH, Franke A, Hubeek I, Boelaarts L, Claus JJ, Korf ESC, van Marum RJ, Roks G, Schoonenboom N, Verwey N, Zwan MD, Wahl S, et al. Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 563-572. PMID 30406175 DOI: 10.1016/j.dadm.2018.08.006 |
0.315 |
|
| 2018 |
Collij L, Konijnenberg E, Reimand J, Ten Kate M, Den Braber A, Lopes Alves I, Zwan M, Yaqub M, Van Assema D, Wink AM, Lammertsma A, Scheltens P, Visser PJ, Barkhof F, Van Berckel B. Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30315145 DOI: 10.2967/Jnumed.118.211532 |
0.337 |
|
| 2018 |
de Wilde A, van der Flier WM, Pelkmans W, Bouwman F, Verwer J, Groot C, van Buchem MM, Zwan M, Ossenkoppele R, Yaqub M, Kunneman M, Smets EMA, Barkhof F, Lammertsma AA, Stephens A, et al. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project. Jama Neurology. PMID 29889941 DOI: 10.1001/Jamaneurol.2018.1346 |
0.395 |
|
| 2017 |
van Maurik IS, Zwan MD, Tijms BM, Bouwman FH, Teunissen CE, Scheltens P, Wattjes MP, Barkhof F, Berkhof J, van der Flier WM. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project. Jama Neurology. PMID 29049480 DOI: 10.1001/Jamaneurol.2017.2712 |
0.304 |
|
| 2017 |
de Wilde A, van Maurik IS, Kunneman M, Bouwman F, Zwan M, Willemse EA, Biessels GJ, Minkman M, Pel R, Schoonenboom NS, Smets EM, Wattjes MP, Barkhof F, Stephens A, van Lier EJ, et al. Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 143-151. PMID 28239639 DOI: 10.1016/J.Dadm.2017.01.003 |
0.4 |
|
| 2017 |
Zwan MD, Bouwman FH, Konijnenberg E, van der Flier WM, Lammertsma AA, Verhey FR, Aalten P, van Berckel BN, Scheltens P. Diagnostic impact of [(18)F]flutemetamol PET in early-onset dementia. Alzheimer's Research & Therapy. 9: 2. PMID 28093088 DOI: 10.1186/S13195-016-0228-4 |
0.321 |
|
| 2016 |
de Wilde A, van der Flier WM, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Newman V, Lammertsma AA, van Berckel BN, Scheltens P. P1-297: The Diagnostic Value of Amyloid Pet in an Unselected Cohort of Memory Clinic Patients Alzheimer's & Dementia. 12: P534-P535. DOI: 10.1016/j.jalz.2016.06.1047 |
0.308 |
|
| 2016 |
Wilde Ad, Flier WMvd, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Newman V, Lammertsma AA, Berckel BNMv, Scheltens P. The Diagnostic Value Of Amyloid Pet In An Unselected Cohort Of Memory Clinic Patients Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.021 |
0.318 |
|
| 2015 |
Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, et al. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. Journal of Alzheimer's Disease : Jad. PMID 26639956 DOI: 10.3233/Jad-150446 |
0.312 |
|
| 2015 |
Zwan MD, Rinne JO, Hasselbalch SG, Nordberg A, Lleó A, Herukka SK, Soininen H, Law I, Bahl JM, Carter SF, Fortea J, Blesa R, Teunissen CE, Bouwman FH, van Berckel BN, et al. Use of amyloid-PET to determine cutpoints for CSF markers: A multicenter study. Neurology. PMID 26468410 DOI: 10.1212/Wnl.0000000000002081 |
0.348 |
|
| 2015 |
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669 |
0.388 |
|
| 2014 |
Zwan MD, Okamura N, Fodero-Tavoletti MT, Furumoto S, Masters CL, Rowe CC, Villemagne VL. Voyage au bout de la nuit: Aβ and tau imaging in dementias. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 58: 398-412. PMID 25358680 |
0.357 |
|
| 2014 |
Zwan MD, Ossenkoppele R, Tolboom N, Beunders AJ, Kloet RW, Adriaanse SM, Boellaard R, Windhorst AD, Raijmakers P, Adams H, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Comparison of simplified parametric methods for visual interpretation of 11C-Pittsburgh compound-B PET images. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1305-7. PMID 24898026 DOI: 10.2967/Jnumed.114.139121 |
0.307 |
|
| 2014 |
Ossenkoppele R, van der Flier WM, Verfaillie SC, Vrenken H, Versteeg A, van Schijndel RA, Sikkes SA, Twisk J, Adriaanse SM, Zwan MD, Boellaard R, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, et al. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions. Neurology. 82: 1768-75. PMID 24748672 DOI: 10.1212/Wnl.0000000000000432 |
0.357 |
|
| 2014 |
Zwan M, van Harten A, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, Lammertsma A, Scheltens P, van Berckel B, van der Flier W. Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort. Journal of Alzheimer's Disease : Jad. 41: 801-7. PMID 24705549 DOI: 10.3233/Jad-132561 |
0.448 |
|
| 2014 |
Adriaanse SM, van Dijk KR, Ossenkoppele R, Reuter M, Tolboom N, Zwan MD, Yaqub M, Boellaard R, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Barkhof F, van Berckel BN. The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 41: 1190-8. PMID 24615466 DOI: 10.1007/S00259-014-2704-Z |
0.309 |
|
| 2013 |
Ossenkoppele R, van der Flier WM, Zwan MD, Adriaanse SF, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van Berckel BN. Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia. Neurology. 80: 359-65. PMID 23255822 DOI: 10.1212/Wnl.0B013E31827F0889 |
0.358 |
|
| 2013 |
Zwan M, Harten Av, Ossenkoppele R, Bouwman F, Teunissen C, Adriaanse S, Lammertsma A, Scheltens P, Berckel BNMv, Flier WVd. Concordance between CSF biomarkers and [11C]PiB-PET in a memory clinic population Alzheimers & Dementia. 9: 13. DOI: 10.1016/J.Jalz.2013.05.008 |
0.348 |
|
| 2012 |
Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement. Brain : a Journal of Neurology. 135: 2115-25. PMID 22556189 DOI: 10.1093/Brain/Aws113 |
0.306 |
|
| 2012 |
Flier WVd, Ossenkoppele R, Adriaanse S, Zwan M, Boellaard R, Windhorst A, Barkhof F, Scheltens P, Lammertsma A, Berckel Bv. Differential impact of apolipoprotein E genotype on distributions of amyloid load and glucose metabolism in Alzheimer's disease Alzheimers & Dementia. 8: 618. DOI: 10.1016/J.Jalz.2012.05.1646 |
0.309 |
|
| 2012 |
Ossenkoppele R, Zwan M, Tolboom N, Assema DME, Adriaanse S, Barkhof F, Lammertsma A, Scheltens P, Flier WVd, Berckel Bv. Increased parietal amyloid burden and metabolic dysfunction in Alzheimer's disease Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.119 |
0.358 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2017 |
Wilde Ad, Pelkmans W, Bouwman FH, Verwer J, Groot C, Buchem Mv, Zwan MD, Ossenkoppele R, Yaqub MM, Kunneman M, Smets EM, Barkhof F, Lammertsma AA, Stephens A, Lier Ev, et al. The Impact Of Amyloid Pet On Diagnosis And Patient Management In An Unselected Memory Clinic Cohort: The Abide Project Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.08.004 |
0.297 |
|
| 2017 |
Wilde Ad, Flier WMvd, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Teunissen CE, Stephens A, Lammertsma AA, Berckel BNMv, Scheltens P. CONCORDANCE BETWEEN CEREBROSPINAL FLUID AMYLOID-β AND [ 18 F]FLORBETABEN PET IN AN UNSELECTED COHORT OF MEMORY CLINIC PATIENTS Alzheimers & Dementia. 13: 688. DOI: 10.1016/J.Jalz.2017.06.2277 |
0.297 |
|
| 2015 |
Zwan MD, Bouwman F, Konijnenburg E, Flier WMvd, Lammertsma AA, Berckel BNMv, Scheltens P. Diagnostic impact of [18F]flutemetamol amyloid imaging in young onset dementia Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.005 |
0.296 |
|
| 2015 |
Scheltens P, Zwan MD, Bouwman F, Berckel BNMv. Diagnostic impact of biomarkers including CSF and PET in a tertiary memory clinic Alzheimers & Dementia. 11: 263. DOI: 10.1016/J.Jalz.2015.07.340 |
0.296 |
|
| 2021 |
Boada M, Rodrigo A, Jessen F, Wimblad B, Kramberger M, Visser PJ, Simó R, Rodríguez-Gomez O, Ciudin A, Georges J, Dumas A, Maguire P, Krivec D, Wimo A, Valero S, ... ... Zwan M, et al. Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease: Results from the MOPEAD project. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34310061 DOI: 10.1002/alz.12441 |
0.295 |
|
| 2017 |
de Wilde A, van der Flier WM, Bouwman FH, Ossenkoppele R, Pelkmans W, Groot C, Zwan MD, Yaqub MM, Teunissen CE, Stephens A, Lammertsma AA, van Berckel BN, Scheltens P. [P2-207]: CONCORDANCE BETWEEN CEREBROSPINAL FLUID AMYLOID-β AND [18
F]FLORBETABEN PET IN AN UNSELECTED COHORT OF MEMORY CLINIC PATIENTS Alzheimer's & Dementia. 13: P688-P688. DOI: 10.1016/j.jalz.2017.06.858 |
0.292 |
|
| 2012 |
Adriaanse S, Dijk Kv, Ossenkoppele R, Reuter M, Tolboom N, Zwan M, Yaqub M, Boellaard R, Windhorst A, Flier WVd, Scheltens P, Barkhof F, Lammertsma A, Berckel Bv. Exploring the biomarker cascade model: Relating cortical volume loss to [11C]PiB, [18F]FDG and MMSE over time in Alzheimer's disease patients and normal controls Alzheimers & Dementia. 8: 32. DOI: 10.1016/J.Jalz.2012.05.081 |
0.292 |
|
| 2018 |
Collij L, Konijnenberg E, Reimand J, Kate Mt, Braber Ad, Alves IL, Zwan MD, Yaqub MM, Assema Dv, Wink AM, Lammertsma AA, Scheltens P, Visser PJ, Barkhof F, Berckel BNMv. Assessment Of Early Amyloid Pathology Using [18F]Flutemetamol Positron Emission Tomography: Comparing Visual Read, Semi-Quantitative And Quantitative Methods Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2069 |
0.291 |
|
| 2018 |
Tijms BM, Vermunt L, Zwan MD, van Harten AC, van der Flier WM, Teunissen CE, Scheltens P, Visser PJ. Pre-amyloid stage of Alzheimer's disease in cognitively normal individuals. Annals of Clinical and Translational Neurology. 5: 1037-1047. PMID 30250861 DOI: 10.1002/Acn3.615 |
0.288 |
|
| 2017 |
Tijms BM, Willemse EAJ, Zwan MD, Mulder SD, Visser PJ, van Berckel BNM, van der Flier WM, Scheltens P, Teunissen CE. Unbiased Approach to Counteract Upward Drift in Cerebrospinal Fluid Amyloid-β 1-42 Analysis Results. Clinical Chemistry. PMID 29208658 DOI: 10.1373/Clinchem.2017.281055 |
0.286 |
|
| 2006 |
Collij L, Konijnenberg E, Reimand J, ten Kate M, den Braber A, Alves IL, Zwan MD, Yaqub MM, van Assema D, Wink AM, Lammertsma AA, Scheltens P, Visser PJ, Barkhof F, van Berckel BN. P3-355: ASSESSMENT OF EARLY AMYLOID PATHOLOGY USING [18
F]FLUTEMETAMOL POSITRON EMISSION TOMOGRAPHY: COMPARING VISUAL READ, SEMI-QUANTITATIVE AND QUANTITATIVE METHODS Alzheimer's & Dementia. 14: P1221-P1222. DOI: 10.1016/j.jalz.2018.06.1717 |
0.286 |
|
| 2015 |
Zwan MD, Bouwman F, Konijnenburg E, van der Flier WM, Lammertsma AA, van Berckel BN, Scheltens P. P1-174: Diagnostic impact of [18
F]flutemetamol amyloid imaging in young onset dementia Alzheimer's & Dementia. 11: P411-P412. DOI: 10.1016/j.jalz.2015.06.373 |
0.284 |
|
| 2021 |
Wimo A, Belger M, Bon J, Jessen F, Dumas A, Kramberger MG, Jamilis L, Johansson G, Rodrigo Salas A, Rodríguez Gómez O, Sannemann L, Stoekenbroek M, Gurruchaga Telleria M, Valero S, Vermunt L, ... ... Zwan M, et al. A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project. Journal of Alzheimer's Disease : Jad. PMID 34420954 DOI: 10.3233/JAD-210303 |
0.276 |
|
| 2020 |
Verberk IMW, Thijssen E, Koelewijn J, Mauroo K, Vanbrabant J, de Wilde A, Zwan MD, Verfaillie SCJ, Ossenkoppele R, Barkhof F, van Berckel BNM, Scheltens P, van der Flier WM, Stoops E, Vanderstichele HM, et al. Combination of plasma amyloid beta and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimer's Research & Therapy. 12: 118. PMID 32988409 DOI: 10.1186/s13195-020-00682-7 |
0.274 |
|
| 2019 |
van Maurik IS, Slot RER, Verfaillie SCJ, Zwan MD, Bouwman FH, Prins ND, Teunissen CE, Scheltens P, Barkhof F, Wattjes MP, Molinuevo JL, Rami L, Wolfsgruber S, Peters O, Jessen F, et al. Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project. Alzheimer's Research & Therapy. 11: 33. PMID 30987684 DOI: 10.1186/S13195-019-0487-Y |
0.273 |
|
| 2012 |
Zwan M, Ossenkoppele R, Tolboom N, Beunders A, Kloet R, Adriaanse S, Boellaard R, Windhorst A, Lammertsma A, scheltens P, Flier WVd, Adams H, Berckel Bv. Visual assessment of parametric [11C]PiB images Alzheimers & Dementia. 8: 24. DOI: 10.1016/J.Jalz.2012.05.067 |
0.272 |
|
| 2021 |
Sannemann L, Müller T, Waterink L, Zwan M, Wimo A, Stomrud E, Pinó S, Arrufat J, Rodríguez-Gomez O, Benaque A, Bon J, Ferreira D, Johansson G, Dron A, Dumas A, et al. General practitioners' attitude toward early and pre-dementia diagnosis of AD in five European countries-A MOPEAD project survey. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12130. PMID 33665337 DOI: 10.1002/dad2.12130 |
0.263 |
|
| 2024 |
Waterink L, Masselink LA, van der Lee SJ, Visser LNC, Cleutjens S, van der Schaar J, van Harten AC, Scheltens P, Sikkes SAM, van der Flier WM, Zwan MD. Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study. Alzheimer's Research & Therapy. 16: 1. PMID 38167083 DOI: 10.1186/s13195-023-01364-w |
0.251 |
|
| 2022 |
Wang J, Guo C, Meng Z, Zwan MD, Chen X, Seelow S, Lundström SL, Rodin S, Teunissen CE, Zubarev RA. Testing the link between isoaspartate and Alzheimer's disease etiology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35924765 DOI: 10.1002/alz.12735 |
0.244 |
|
| 2020 |
Vermunt L, Muniz-Terrera G, Ter Meulen L, Veal C, Blennow K, Campbell A, Carrié I, Delrieu J, Fauria K, Huesa Rodríguez G, Ingala S, Jenkins N, Molinuevo JL, Ousset PJ, Porteous D, ... ... Zwan M, et al. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings. Alzheimer's Research & Therapy. 12: 8. PMID 31907067 DOI: 10.1186/S13195-019-0576-Y |
0.244 |
|
| 2019 |
van Maurik IS, Visser LN, Pel-Littel RE, van Buchem MM, Zwan MD, Kunneman M, Pelkmans W, Bouwman FH, Minkman M, Schoonenboom N, Scheltens P, Smets EM, van der Flier WM. Development and Usability of ADappt: Web-Based Tool to Support Clinicians, Patients, and Caregivers in the Diagnosis of Mild Cognitive Impairment and Alzheimer Disease. Jmir Formative Research. 3: e13417. PMID 31287061 DOI: 10.2196/13417 |
0.243 |
|
| 2014 |
Zwan MD, Bouwman FH, Van der Flier WM, Lammertsma A, van Berckel B, Scheltens P. O4-01-01: DIAGNOSTIC VALUE OF AMYLOID IMAGING IN EARLY ONSET DEMENTIA Alzheimer's & Dementia. 10: P248-P248. DOI: 10.1016/j.jalz.2014.04.384 |
0.242 |
|
| 2014 |
Zwan MD, Bouwman FH, Van der Flier WM, Lammertsma A, van Berckel B, Scheltens P. IC-P-013: DIAGNOSTIC VALUE OF AMYLOID IMAGING IN EARLY ONSET DEMENTIA Alzheimer's & Dementia. 10: P14-P14. DOI: 10.1016/J.Jalz.2014.05.017 |
0.222 |
|
| 2022 |
Fruijtier AD, van der Schaar J, van Maurik IS, Zwan MD, Scheltens P, Bouwman F, Pijnenburg YAL, van Berckel BNM, Ebenau J, van der Flier WM, Smets EMA, Visser LNC. Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35366050 DOI: 10.1002/alz.12630 |
0.222 |
|
| 2018 |
Golla SS, Verfaillie SC, Boellaard R, Adriaanse SM, Zwan MD, Schuit RC, Timmers T, Groot C, Schober P, Scheltens P, van der Flier WM, Windhorst AD, van Berckel BN, Lammertsma AA. Quantification of [F]florbetapir: A test-retest tracer kinetic modelling study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X18783628. PMID 29897009 DOI: 10.1177/0271678X18783628 |
0.209 |
|
| 2017 |
Kunneman M, Smets EMA, Bouwman FH, Schoonenboom NSM, Zwan MD, Pel-Littel R, van der Flier WM. Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project. Alzheimer's & Dementia (New York, N. Y.). 3: 305-313. PMID 29067337 DOI: 10.1016/j.trci.2017.03.009 |
0.206 |
|
| 2018 |
Rodriguez-Gomez O, Campo L, Datto C, Hundemer HP, Winblad B, Johansson G, Wimo A, Jessen F, Sannemann L, Visser PJ, Zwan MD, Kramberger MG, Simó R, Pérez-Garro I, Rodrigo A, et al. P3‐304: Models Of Patient Engagement In Alzheimer'S Disease (Mopead): A European Multinational Project To Develop And Test Innovative Patient Engagement Strategies Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1665 |
0.203 |
|
| 2019 |
Maurik ISV, Visser LNC, Pel-Littel R, Buchem Mv, Zwan MD, Kunneman M, Pelkmans W, Bouwman FH, Minkman M, Schoonenboom NSM, Scheltens P, Smets EM, Flier WMvd. Development And Usability Of Adappt: An Online Tool To Support Clinicians, Patients And Caregivers In The Diagnosis Of Mild Cognitive Impairment And Alzheimer’S Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4336 |
0.201 |
|
| 2016 |
Tijms BM, Bertens D, Zwan MD, Slot RER, Teunissen CE, Flier WMvd, Scheltens P, Visser PJ. Amyloid Levels In The Normal Range Are Predictive For Incident Dementia In Non-Demented Elderly Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.2203 |
0.197 |
|
| 2023 |
Bakker ED, van der Pas SL, Zwan MD, Gillissen F, Bouwman FH, Scheltens P, van der Flier WM, van Maurik IS. Steeper memory decline after COVID-19 lockdown measures. Alzheimer's Research & Therapy. 15: 81. PMID 37061745 DOI: 10.1186/s13195-023-01226-5 |
0.194 |
|
| 2021 |
Bayoumy S, Verberk IMW, den Dulk B, Hussainali Z, Zwan M, van der Flier WM, Ashton NJ, Zetterberg H, Blennow K, Vanbrabant J, Stoops E, Vanmechelen E, Dage JL, Teunissen CE. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231. Alzheimer's Research & Therapy. 13: 198. PMID 34863295 DOI: 10.1186/s13195-021-00939-9 |
0.191 |
|
| 2014 |
Hasselbalch S, Zwan MD, Rinne J, Lleó A, van Berckel B, Visser PJ. O2-05-03: USE OF CSF AMYLOID FOR DETECTING CORTICAL AMYLOID DEPOSITION: A MULTICENTER STUDY Alzheimer's & Dementia. 10: P173-P173. DOI: 10.1016/j.jalz.2014.04.182 |
0.19 |
|
| 2024 |
Postema MC, Dubbelman MA, Claesen J, Ritchie C, Verrijp M, Visser L, Visser PJ, Zwan MD, van der Flier WM, Sikkes SAM. Facilitating clinical use of the Amsterdam Instrumental Activities of Daily Living Questionnaire: Normative data and a diagnostic cutoff value. Journal of the International Neuropsychological Society : Jins. 1-6. PMID 38456286 DOI: 10.1017/S1355617724000031 |
0.184 |
|
| 2014 |
Zwan MD, Rinne J, Hasselbalch S, Lleó A, van Berckel B, Visser PJ. IC-P-014: USE OF CSF AMYLOID FOR DETECTING CORTICAL AMYLOID DEPOSITION: A MULTICENTER STUDY Alzheimer's & Dementia. 10: P14-P14. DOI: 10.1016/j.jalz.2014.05.018 |
0.179 |
|
| 2019 |
Altomare D, de Wilde A, Ossenkoppele R, Pelkmans W, Bouwman F, Groot C, van Maurik I, Zwan M, Yaqub M, Barkhof F, van Berckel BN, Teunissen CE, Frisoni GB, Scheltens P, van der Flier WM. Applying the ATN scheme in a memory clinic population: The ABIDE project. Neurology. PMID 31597710 DOI: 10.1212/Wnl.0000000000008361 |
0.176 |
|
| 2024 |
Bakker ED, van Maurik IS, Zwan MD, Gillissen F, van der Veere PJ, Bouwman FH, Pijnenburg YAL, van der Flier WM. Impact of COVID-19 pandemic on mortality rate in memory clinic patients. Alzheimer's & Dementia (Amsterdam, Netherlands). 16: e12541. PMID 38288266 DOI: 10.1002/dad2.12541 |
0.171 |
|
| 2019 |
Fruijtier AD, Visser LNC, van Maurik IS, Zwan MD, Bouwman FH, van der Flier WM, Smets EMA. ABIDE Delphi study: topics to discuss in diagnostic consultations in memory clinics. Alzheimer's Research & Therapy. 11: 77. PMID 31472676 DOI: 10.1186/s13195-019-0531-y |
0.167 |
|
| 2020 |
Masselink LA, Visser LN, Cleutjens S, van der Lee SJ, van der Schaar J, Scheltens P, van Der Flier W, Zwan MD. Attitudes towards genetic susceptibility testing for Alzheimer’s disease dementia in cognitively normal adults: A survey study Alzheimer's & Dementia. 16. DOI: 10.1002/alz.047393 |
0.159 |
|
| 2021 |
Visser LNC, Dubbelman MA, Verrijp M, Wanders L, Pelt S, Zwan MD, Thijssen DHJ, Wouters H, Sikkes SAM, van Hout HPJ, van der Flier WM. The Cognitive Online Self-Test Amsterdam (COST-A): Establishing norm scores in a community-dwelling population. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12234. PMID 34541288 DOI: 10.1002/dad2.12234 |
0.153 |
|
| 2021 |
Visser LNC, Minguillon C, Sánchez-Benavides G, Abramowicz M, Altomare D, Fauria K, Frisoni GB, Georges J, Ribaldi F, Scheltens P, van der Schaar J, Zwan M, van der Flier WM, Molinuevo JL. Dementia risk communication. A user manual for Brain Health Services-part 3 of 6. Alzheimer's Research & Therapy. 13: 170. PMID 34635169 DOI: 10.1186/s13195-021-00840-5 |
0.15 |
|
| 2019 |
Visser LNC, Kunneman M, Murugesu L, van Maurik I, Zwan M, Bouwman FH, Schuur J, Wind HA, Blaauw MSJ, Kragt JJ, Roks G, Boelaarts L, Schipper AC, Schooneboom N, Scheltens P, et al. Clinician-patient communication during the diagnostic workup: The ABIDE project. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 520-528. PMID 31388556 DOI: 10.1016/J.Dadm.2019.06.001 |
0.146 |
|
| 2020 |
Winblad B, Jessen F, Kramberger MG, Visser PJ, Rodrigo A, Jamilis L, Rodriguez‐Gomez O, Sannemann L, Zwan MD, Bon J, Johansson G, Nelvig A, Haglund A, Jelic V, Campo L, et al. The IMI‐EU H2020 project MOPEAD: Outcome of different screening methods to identify MCI/early AD Alzheimer's & Dementia. 16. DOI: 10.1002/alz.044524 |
0.141 |
|
| 2022 |
Bakker ED, van Maurik IS, Mank A, Zwan MD, Waterink L, van den Buuse S, van den Broeke JR, Gillissen F, van de Beek M, Lemstra E, van den Bosch KA, van Leeuwenstijn M, Bouwman FH, Scheltens P, van der Flier WM. Psychosocial Effects of COVID-19 Measures on (Pre-)Dementia Patients During Second Lockdown. Journal of Alzheimer's Disease : Jad. PMID 35034903 DOI: 10.3233/JAD-215342 |
0.137 |
|
| 2022 |
Verrijp M, Dubbelman MA, Visser LNC, Jutten RJ, Nijhuis EW, Zwan MD, van Hout HPJ, Scheltens P, van der Flier WM, Sikkes SAM. Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report. Frontiers in Aging Neuroscience. 13: 761932. PMID 35069172 DOI: 10.3389/fnagi.2021.761932 |
0.126 |
|
| 2020 |
Jeon Y, Fargo K, Smith A, Langbaum JB, Nosheny RL, Zwan MD, Shin M, Scheltens P, Weiner MW, Rossor MN. Comparison of digital platforms for participant recruitment in dementia research: Lessons and future directions from a global collaborative Alzheimer's & Dementia. 16. DOI: 10.1002/alz.046401 |
0.123 |
|
| 2015 |
Wilde Ad, Bouwman F, Zwan MD, Biessels GJ, Minkman M, Schoonenboom NSM, Smets EM, Wattjes M, Schaeuble B, Batrla-Utermann R, Scheltens P, Teunissen CE, Berckel BNMv, Flier WMvd. Alzheimer’s biomarkers in daily practice (ABIDE): Study design Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.06.1010 |
0.12 |
|
| 2016 |
Kunneman M, van der Flier WM, Bouwman FH, Gillissen F, Schoonenboom NS, Zwan MD, Pel-Littel R, Smets EM. P4-240: Deciding About Diagnostic Testing for Alzheimer’s Disease: Patients’ Views and Experiences Alzheimer's & Dementia. 12: P1122-P1122. DOI: 10.1016/j.jalz.2016.06.2332 |
0.119 |
|
| 2020 |
Verrijp M, Dubbelman MA, Nijhuis EW, Visser LN, Zwan MD, Jutten RJ, Van Hout HP, van Der Flier W, Scheltens P, Sikkes SA. Study partner‐ and self‐reported difficulties in cognitively complex everyday activities in participants without objective cognitive impairment Alzheimer's & Dementia. 16. DOI: 10.1002/alz.046015 |
0.105 |
|
| 2018 |
Zwan MD, Flenniken D, Finley S, Ulbricht A, Nosheny R, Flier WMVd, Sikkes SAM, Scheltens P, Truran-Sacrey D, Weiner M, Prins ND. P1-602: Dutch Online Registry For Recruitment Of Participants For Dementia Studies: Hersenonderzoek.Nl And Brain Health Registry Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.615 |
0.105 |
|
| 2017 |
Zwan MD, Flenniken D, Finley S, Nosheny R, Sikkes SA, van der Flier WM, Scheltens P, Weiner M, Prins ND. [P2-052]: THE DUTCH BRAIN HEALTH REGISTRY: OPTIMIZING RECRUITMENT FOR DEMENTIA RESEARCH Alzheimer's & Dementia. 13: P624-P624. DOI: 10.1016/J.Jalz.2017.06.701 |
0.105 |
|
| 2023 |
Neal DP, Ettema TP, Zwan MD, Dijkstra K, Finnema E, Graff M, Muller M, Dröes RM. FindMyApps compared with usual tablet use to promote social health of community-dwelling people with mild dementia and their informal caregivers: a randomised controlled trial. Eclinicalmedicine. 63: 102169. PMID 37680943 DOI: 10.1016/j.eclinm.2023.102169 |
0.096 |
|
| 2016 |
Kunneman M, van der Flier WM, Bouwman FH, Schoonenboom NS, Zwan MD, Pel-Littel R, Smets EM. P1-418: Clinicians’ Views and Attitudes on Shared Decision Making in Diagnostic Testing for Alzheimer’s Disease Alzheimer's & Dementia. 12: P595-P595. DOI: 10.1016/j.jalz.2016.06.1171 |
0.092 |
|
| 2021 |
Zwan MD, van der Flier WM, Cleutjens S, Schouten TC, Vermunt L, Jutten RJ, van Maurik IS, Sikkes SAM, Flenniken D, Howell T, Weiner MW, Scheltens P, Prins ND. Dutch Brain Research Registry for study participant recruitment: Design and first results. Alzheimer's & Dementia (New York, N. Y.). 7: e12132. PMID 33614897 DOI: 10.1002/trc2.12132 |
0.072 |
|
| 2020 |
Boada M, Winblad B, Jessen F, Visser PJ, Kramberger MG, Rodrigo A, Simó R, Rodriguez O, Sannemann L, Bon J, Zwan MD, Alegret M, Sanabria A, Rosende‐Roca M, Krivec D, et al. Pre‐screening models for patient engagement: The MOPEAD project Alzheimer's & Dementia. 16. DOI: 10.1002/alz.044796 |
0.07 |
|
| 2022 |
Waterink L, Bakker ED, Visser LNC, Mangialasche F, Kivipelto M, Deckers K, Köhler S, Sikkes SAM, Prins ND, Scheltens P, van der Flier WM, Zwan MD. Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions. Frontiers in Psychiatry. 13: 877460. PMID 35722572 DOI: 10.3389/fpsyt.2022.877460 |
0.05 |
|
| 2014 |
Ishihara R, Zhang J, Zwan MVD, Trifunovic M, Takagishi H, Shimoda T. Solution processed single-grain Si TFTs on a plastic substrate Digest of Technical Papers - Sid International Symposium. 45: 439-442. DOI: 10.1002/j.2168-0159.2014.tb00118.x |
0.01 |
|
| Hide low-probability matches. |